Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis

Joseph Hinchey(Yeshiva University), Sunhee Lee(Howard Hughes Medical Institute), Bo‐Young Jeon(United States Food and Drug Administration), Randall J. Basaraba(Colorado State University), Manjunatha M. Venkataswamy(Yeshiva University), Bing Chen(Yeshiva University), John Chan(Albert Einstein College of Medicine), Miriam Braunstein(University of North Carolina at Chapel Hill), Ian M. Orme(Colorado State University), Steven C. Derrick(Center for Biologics Evaluation and Research), Sheldon L. Morris(United States Food and Drug Administration), William R. Jacobs(Howard Hughes Medical Institute), Steven A. Porcelli(Yeshiva University)
Journal of Clinical Investigation
August 1, 2007
Cited by 283Open Access
Full Text

Abstract

The inhibition of apoptosis of infected host cells is a well-known but poorly understood function of pathogenic mycobacteria. We show that inactivation of the secA2 gene in Mycobacterium tuberculosis, which encodes a component of a virulence-associated protein secretion system, enhanced the apoptosis of infected macrophages by diminishing secretion of mycobacterial superoxide dismutase. Deletion of secA2 markedly increased priming of antigen-specific CD8 + T cells in vivo, and vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-Gurin vaccination. Our results define a mechanism for a key immune evasion strategy of M. tuberculosis and provide what we believe to be a novel approach for improving mycobacterial vaccines.


Related Papers

No related papers found

Powered by citation graph analysis